Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-11-05 13:17Core Viewpoint - The stock of Steady Medical (300888) has shown a slight increase in price, with significant fluctuations in capital flow, indicating mixed investor sentiment and potential growth in the healthcare sector [1][2]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main business revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3] - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year [3] - The third quarter alone saw a main business revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, up 42.11% year-on-year [3] - The company’s gross profit margin stands at 48.32%, which is higher than the industry average of 42.35% [3] Market Position - Steady Medical has a total market capitalization of 23.619 billion yuan, ranking 4th in the beauty and personal care industry [3] - The company has a net asset value of 12.263 billion yuan, ranking 1st in the industry [3] - The price-to-earnings ratio (P/E) is 24.2, which is lower than the industry average of 38.73, indicating a potentially undervalued stock [3] Capital Flow Analysis - On November 5, 2025, the stock experienced a net outflow of 11.2619 million yuan from main funds, accounting for 5.81% of the total transaction volume [1][2] - Retail investors showed a net inflow of 5.3821 million yuan, representing 2.78% of the total transaction volume [1][2] - Over the past five days, the stock has seen varying capital flows, with significant fluctuations in both institutional and retail investor activities [2] Analyst Ratings - In the last 90 days, 21 institutions have rated the stock, with 17 buy ratings and 4 hold ratings [4] - The average target price set by institutions is 5.383 billion yuan, indicating a potential upside from the current trading price [4]